Episode 420: Long-Term Myelodysplastic Syndrome Considerations for Oncology Nurses
From The ONS Podcast · · 43 min
This plays from the publisher's own server. We do not host a copy.
Description
"We typically think of the disease progressing for our higher-risk patients because many of them already start with increased blasts or a lot of dysplasia. And they have these chromosomal variants that make them prone to evolving into acute myeloid leukemia (AML). With them, we can anticipate that they are going to progress to AML. And that's what we're trying to prevent. It's kind of like a biologic evolution and not a switch," ONS member Sara Tinsley-Vance, PhD, APRN, AOCN®, nurse practitioner and quality-of-life researcher at Moffitt Cancer Center in Tampa, FL, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term myelodysplastic syndrome (MDS) considerations for oncology nurses.
Music Credit: "Fireflies and Stardust (http://www.incompetech.com/)" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 19, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to myelodysplastic syndrome and its treatment.
Episode Notes - Complete this evaluation for free NCPD.
- ONS Podcast™ episodes: - Episode 415: Myelodysplastic Syndrome Treatment Considerations for Oncology Nurses
- Episode 411: An Overview of Myelodysplastic Syndrome for Oncology Nurses
- Episode 256: Cancer Symptom Management Basics: Hematologic Complications
- Episode 220: Oncologic Emergencies 101: Febrile Neutropenia and Sepsis
- Clinical Journal of Oncology Nursing articles: - Exploring Experiences of Bereaved Caregivers of Older Adult Patients With Acute Myeloid Leukemia
- Family Caregiver Preparedness: Developing an Educational Intervention for Symptom Management
- Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery
- Oncology Nursing Forum article: An Integrative Review of Sex Differences in Quality of Life and Symptoms Among Survivors of Hematologic Malignancies
- ONS book: BMTCN® Certification Review Manual (second edition)
- ONS course: Psychosocial Dimensions of Cancer Care™
- ONS Learning Libraries: - Survivorship Learning Library
- Hematology, Cellular Therapy, and Stem Cell Transplantation
- Survivorship Care Plan Huddle Card
- American Association of Colleges of Nursing End-of-Life Nursing Education Consortium (ELNEC) (https://www.aacnnursing.org/elnec)
- American Cancer Society: Living As a Myelodysplastic Syndrome Survivor
- American Society of Hematology (https://www.hematology.org/)
- Aplastic Anemia and MDS International Foundation: MDS Toolkit (https://www.aamds.org/mds/toolkit)
- Blood Cancer United: Myelodysplastic Syndromes
- Family Caregiver Alliance (https://www.caregiver.org)
- HealthTree Foundation (https://healthtree.org/)
- Inspire: MDS Support and Discussion Community
- Myelodysplastic Syndromes Foundation (https://www.mds-foundation.org/)
To discuss the information in this episode with other oncology nurses, visit the ONS Communities (http://communities.ons.org/).
To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library.
To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Highlights From This Episode "When our higher-risk patients have disease-related progression, their [malignancy] can transform to AML. And we know this occurs in about one-third of our patients and is one of the most serious late effects. Even in lower-risk disease, we have this worsening marrow failure with or without increasing…